1-(5-isoquinolinesulfonyl)-2-methylpiperazine has been researched along with Fungal Lung Diseases in 1 studies
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine: A specific protein kinase C inhibitor, which inhibits superoxide release from human neutrophils (PMN) stimulated with phorbol myristate acetate or synthetic diacylglycerol.
1-(5-isoquinolinesulfonyl)-2-methylpiperazine : A member of the class of N-sulfonylpiperazines that is 2-methylpiperazine substituted at position 1 by a 5-isoquinolinesulfonyl group.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Nagayoshi, M | 1 |
Tada, Y | 1 |
West, J | 1 |
Ochiai, E | 1 |
Watanabe, A | 1 |
Toyotome, T | 1 |
Tanabe, N | 1 |
Takiguchi, Y | 1 |
Shigeta, A | 1 |
Yasuda, T | 1 |
Shibuya, K | 1 |
Kamei, K | 1 |
Tatsumi, K | 1 |
1 other study available for 1-(5-isoquinolinesulfonyl)-2-methylpiperazine and Fungal Lung Diseases
Article | Year |
---|---|
Inhalation of Stachybotrys chartarum evokes pulmonary arterial remodeling in mice, attenuated by Rho-kinase inhibitor.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Cytokines; Disease Models, Animal; Lung; Lun | 2011 |